Effects of endurance exercise on incidence and severity of cognitive impairments and other therapy-related side effects in leukemia and lymphoma patients undergoing high-dose chemotherapy. A randomized controlled trial.
Not Applicable
Recruiting
- Conditions
- C91.0C83.5Acute myeloblastic leukaemia [AML]Lymphoblastic (diffuse) lymphomaC91.8Mature B-cell leukaemia Burkitt-typeBurkitt lymphomaC92.0C83.7Acute lymphoblastic leukaemia [ALL]
- Registration Number
- DRKS00007824
- Lead Sponsor
- Prof. Dr. Wilhelm Bloch Institut für Kreislaufforschung und SportmedizinAbteilung für molekulare und zelluläre SportmedizinDeutsche Sporthochschule Köln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
A Diagnosis of an acute leukemia
- Approach induction therapy or high dose chemotherapie (for example B-ALL-protocol, GMALL-protocol) or protocols with the therapy aim of a stem cell transplantation (for example DHAP-Induction, S-HAM)
Exclusion Criteria
- Age <18 years
- Comorbidities which prohibit physical activity (coronary heart disease, heart failure NYHA>3, orthopedic illness, cerebral spasm, psychological illness)
- A planned surgery
- Metastasis of CNS
- Other medical reasons not to participate in the study
- Cognitive impairment (dementia, MS, apoplex, traumatic brain injury, brain tumor
- Lack of willingness for data tob e saved and further processed
- outpatient therapy, which does not allow training on a regulare basis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method